CDSCO Schedule M (Revised) – What Pharma Companies Must Do
Why the Update Matters
The revised Schedule M strengthens GMP requirements across quality systems, facilities, data integrity and personnel competency. The aim is to align India’s manufacturing norms closer to international benchmarks and enhance product safety, traceability and export readiness.
Key Areas of Change
- Quality Management Systems: Risk-based QMS, process validation, Product Quality Reviews (PQR) and CAPA.
- Facilities & Equipment: Validated HVAC, clean-zone segregation, IQ/OQ/PQ for critical equipment.
- Data Integrity: Electronic records with audit trails, secure access controls and traceability.
- Personnel & Training: Documented competency matrices and periodic verified training programs.
- Environmental & Safety: Better waste management and sustainability alignment.
Practical Steps for Manufacturers
- Conduct a Schedule M gap analysis to prioritise critical upgrades.
- Plan HVAC and cleanroom segregation improvements where needed.
- Strengthen QMS documentation: PQRs, OOS investigation, CAPA workflows.
- Adopt secure ELN/LIMS and implement robust IT controls for data integrity.
- Implement a documented training program with competency assessments.
Aries Drugs has proactively upgraded systems and processes to meet these requirements and supports partners with compliance planning, validation services, and quality documentation.